Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs No BS RX
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict85/ 100
Grade B · #28No BS RX
Six programs across four terms on one public page, four dispensing pharmacies named with addresses, and a no-intro-rate commitment the arithmetic actually supports.
Visit No BS RXThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 85/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. No BS RX still earns its place — anyone who wants to compare every term and every dose level without starting an intake to see a price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results84
92
Real-world results84
97Price honesty90
97
Price honesty90
96Prescriber access84
96
Prescriber access84
88Formulary choice90
88
Formulary choice90
95Cancellation fairness78
95
Cancellation fairness78
93Member support80
93
Member support80
Price, coverage & features
| Metric | CoreAge Rx | No BS RX |
|---|---|---|
| Verdict Score | 94/100 | 85/100 |
| Grade | A | B |
| Semaglutide | $99/mo | $179/mo (compounded; a low-dose program is $140) |
| Tirzepatide | $149/mo | $249/mo (compounded; a low-dose program is $140) |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
No BS RX
What we like
- Names four dispensing pharmacies with street addresses and phone numbers in its Terms — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
- "No Fake Intro Rate — the price on the page is the ongoing program price" is printed as a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
- Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the price table itself
- Six programs times four terms are published on one page with no intake and no account, plus a separately priced sleep program
The caveats
- The same $409 twelve-week block sits under three different monthly rates — worth $11 against the $140 low-dose injectable and $128 against the $179 low-dose oral, presented identically
- The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
- The Terms name four pharmacies and no operating company — there is no LLC or Inc anywhere in them
- No brand-name option, and state availability is not published
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Anyone who wants to compare every term and every dose level without starting an intake to see a price.
Visit No BS RX Read the full No BS RX review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for No BS RX does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.